TickerFacts.

Amneal Pharmaceuticals, Inc. (AMRX): Long-Term Debt

Annual figures by period end, from SEC filings.

$2.57B
As of 2025-12-31
$2.57B
As of 2026-06-30
-0.6%
3-year compound annual growth
-1.5%
5-year compound annual growth
$2.78B2017-12-31: $1.44B2018-12-31: $2.65B2019-12-31: $2.63B2020-12-31: $2.78B2021-12-31: $2.71B2022-12-31: $2.62B2023-12-31: $2.42B2024-12-31: $2.39B2025-12-31: $2.57B$2.57B
2017-12-31 Long-Term Debt (USD) 2025-12-31
Period endedLong-Term DebtChange YoYSource filing
2025-12-31$2.57B+7.8%2026-02-27, Balance as of period end
2024-12-31$2.39B-1.4%2026-02-27, Balance as of period end
2023-12-31$2.42B-7.7%2025-02-28, Balance as of period end
2022-12-31$2.62B-3.3%2024-03-14, Balance as of period end
2021-12-31$2.71B-2.5%2023-03-03, Balance as of period end
2020-12-31$2.78B+5.7%2022-03-01, Balance as of period end
2019-12-31$2.63B-0.8%2021-03-01, Balance as of period end
2018-12-31$2.65B+83.6%2020-03-02, Balance as of period end
2017-12-31$1.44Bn/a2019-03-01, Balance as of period end

Long-Term Debt at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedLong-Term DebtChange YoY
Amneal Pharmaceuticals, Inc. (AMRX)2025-12-31$2.57B+7.8%
Royalty Pharma plc (RPRX)2025-12-31$8.95B+17.6%
Sarepta Therapeutics, Inc. (SRPT)2025-12-31$828.97Mn/a
Jazz Pharmaceuticals plc (JAZZ)2025-12-31$5.36B-12.3%
Elanco Animal Health Inc (ELAN)2025-12-31$3.76B-12.9%
BeOne Medicines Ltd. (ONC)2025-12-31$836.37Mn/a
Organon & Co. (OGN)2025-12-31$8.64B-2.7%
Prestige Consumer Healthcare Inc. (PBH)2026-03-31$993.95M+0.2%
Madrigal Pharmaceuticals, Inc. (MDGL)2025-12-31$339.88M+189.1%

Compare AMRX, RPRX, SRPT, JAZZ side by side · Screen every company in Pharmaceutical Preparations ↗